Through The Economist‘s distinct lens of rigorous analysis and foresight, The Health Care Forum, War on Cancer event, will explore the future of health systems design, technological innovation, provision and finance. This event will focus on innovative approaches and solutions across policy and financing, prevention, early detection, treatment and long-term management of this deadly disease.
New weapons are emerging in the war on cancer thanks to breakthroughs in science, cutting-edge technology and more efficient regulation. According the International Agency for Research on Cancer, the world spends about $320 billion on cancer treatment and prevention each year, but according to this group, half of cancer deaths could be avoided if the money were spent more wisely.
An aging global population and advanced treatment methods mean more people are surviving cancer than ever before. However, collaboration among institutions in the health-care space has still not reached its full potential to truly unleash innovation, efficiency and patient-centricity. Plus, many argue that the bureaucratic and risk-averse business of cancer research remains a major obstacle to winning the war. Meanwhile, oncology drug development is getting only more expensive and challenging.
Yet, the oncology space remains a huge area of opportunity and growth. The hype of big data has brought along with it hope that massive data sets may help both companies and researchers breakdown patient information on cancer that will allow for a more targeted approach for new drugs and diagnostics. But to win the war on cancer, it will take unprecedented collaboration among pharmaceutical companies, hospitals, regulators and insurers to scale innovation and drive down costs.
How can the health ecosystem be reconfigured to democratise and scale innovation in this space so everyone can benefit?
Send this to a friend